Works matching IS 09509232 AND DT 2000 AND VI 19 AND IP 56

Results: 22

The EGF receptor family as targets for cancer therapy.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6550, doi. 10.1038/sj.onc.1204082

By:

Mendelsohn, John;
Baselga, Jose

Publication type:

Article

Development of anticancer drugs targeting the MAP kinase pathway.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6594, doi. 10.1038/sj.onc.1204083

By:

Sebolt-Leopold, Judith S

Publication type:

Article

Small molecule inhibitors of dual specificity protein phosphatases.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6607, doi. 10.1038/sj.onc.1204084

By:

Pestell, Katharine E;
Ducruet, Alexander P;
Wipf, Peter;
Lazo, John S

Publication type:

Article

Small molecule modulators of cyclin-dependent kinases for cancer therapy.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6600, doi. 10.1038/sj.onc.1204085

By:

Senderowicz, Adrian M

Publication type:

Article

STAT proteins: novel molecular targets for cancer drug discovery.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6613, doi. 10.1038/sj.onc.1204086

By:

Turkson, James;
Jove, Richard

Publication type:

Article

Bcl-2 family proteins as targets for anticancer drug design.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6627, doi. 10.1038/sj.onc.1204087

By:

Huang, Ziwei

Publication type:

Article

New agents in cancer clinical trials.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6687, doi. 10.1038/sj.onc.1204088

By:

Adams, Julian;
Elliott, Peter J

Publication type:

Article

Guest Editor.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6549

By:

O'Hagan, Rònàn C;
Tozer, Richard G;
Symons, Marc;
McCormick, Frank;
Hassell, John A

Publication type:

Article

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6680, doi. 10.1038/sj.onc.1204091

By:

Hidalgo, Manuel;
Rowinsky, Eric K

Publication type:

Article

Telomere maintenance mechanisms as a target for drug development.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6632, doi. 10.1038/sj.onc.1204092

By:

Bearss, David J;
Hurley, Laurence H;
Von Hoff, Daniel D

Publication type:

Article

Potential roles of antisense technology in cancer chemotherapy.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6651, doi. 10.1038/sj.onc.1204093

By:

Crooke, Stanley T

Publication type:

Article

Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6660, doi. 10.1038/sj.onc.1204094

By:

Kirn, David

Publication type:

Article

Dendritic cell vaccination for cancer therapy.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6673, doi. 10.1038/sj.onc.1204095

By:

Nestle, Frank O

Publication type:

Article

ONYX-015 selectivity and the p14ARF pathway.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6670, doi. 10.1038/sj.onc.1204096

By:

McCormick, Frank

Publication type:

Article

Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6642, doi. 10.1038/sj.onc.1204097

By:

Zucker, Stanley;
Cao, Jian;
Chen, Wen-Tien

Publication type:

Article

From oncogene to drug: development of small molecule tyrosine kinase inhibitors as anti-tumor and anti-angiogenic agents.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6574, doi. 10.1038/sj.onc.1204102

By:

Morin, Michael J

Publication type:

Article

Design of growth factor antagonists with antiangiogenic and antitumor properties.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6566, doi. 10.1038/sj.onc.1204121

By:

Sebti, Saïd M;
Hamilton, Andrew D

Publication type:

Article

Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: Lessons from mechanism and bench-to-bedside translational studies.

Published in:

Oncogene, 2000, v. 19, n. 56, p. 6584, doi. 10.1038/sj.onc.1204146

By:

Sebti, Saïd M;
Hamilton, Andrew D

Publication type:

Article

Volume 19 author index.

Published in:: Oncogene, 2000, v. 19, n. 56, p. 6693, doi. 10.1038/sj.onc.1204283
Publication type:: Article

Volume 19 keyword index.

Published in:: Oncogene, 2000, v. 19, n. 56, p. 6709, doi. 10.1038/sj.onc.1204284
Publication type:: Article

Volume 19 author index.

Published in:: Oncogene, 2000, v. 19, n. 56, p. 6701, doi. 10.1038/sj.onc.1204285
Publication type:: Article

Volume 19 keyword index.

Published in:: Oncogene, 2000, v. 19, n. 56, p. 6715, doi. 10.1038/sj.onc.1204286
Publication type:: Article